Comparing Anoro Ellipta vs Incruse Ellipta
| Anoro Ellipta (umeclidinium / vilanterol) | Incruse Ellipta (umeclidinium) |
|
|---|
| Anoro Ellipta (umeclidinium / vilanterol) | Incruse Ellipta (umeclidinium) |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Anoro Ellipta is a once-daily, long-acting bronchodilator, used for the maintenance treatment of COPD in adults. Side effects are uncommon and may include a sore throat, diarrhea, pain, sinusitis, or... View more |
Prescription only
Prescribed for COPD - Maintenance, COPD. Incruse Ellipta may also be used for purposes not listed in this medication guide. |
Related suggestions COPD
COPD, Maintenance
Popular comparisons
|
|||||||||||||||
| More about Anoro Ellipta (umeclidinium / vilanterol) | More about Incruse Ellipta (umeclidinium) | ||||||||||||||||
| Ratings & Reviews | |||||||||||||||||
|
Anoro Ellipta has an average rating of 7.1 out of 10 from a total of 70 ratings on Drugs.com. 60% of reviewers reported a positive effect, while 21% reported a negative effect. |
Incruse Ellipta has an average rating of 3.8 out of 10 from a total of 34 ratings on Drugs.com. 26% of reviewers reported a positive effect, while 65% reported a negative effect. |
||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||||||||||
View all Anoro Ellipta side effects |
View all Incruse Ellipta side effects |
||||||||||||||||
| Drug Class | |||||||||||||||||
| Generic Availability | |||||||||||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all Anoro Ellipta prices |
View all Incruse Ellipta prices |
||||||||||||||||
| Dosage Forms | |||||||||||||||||
|
|
||||||||||||||||
| Brand Names | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||||||||||
|
21.3 hours |
11 hours |
||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | |||||||||||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | |||||||||||||||||
|
A total of 504 drugs are known to interact with Anoro Ellipta:
|
A total of 103 drugs are known to interact with Incruse Ellipta:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
| Disease Interactions | |||||||||||||||||
| First Approval Date | |||||||||||||||||
|
December 18, 2013 |
April 30, 2014 |
||||||||||||||||
| WADA Class View classifications | |||||||||||||||||
|
N/A |
|||||||||||||||||
| More Information | |||||||||||||||||
| Patient Resources | |||||||||||||||||
| Professional Resources | |||||||||||||||||
| Related Treatment Guide | |||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.